Co-founder, Chief Executive Officer & Director

With more than thirty years of executive, general management, business development, sales, marketing, and technology commercialization experience, Mr. Sharp’s career spans private venture-backed businesses, mid-size, and Fortune 100 public companies in the medical device, diagnostics, and life science tools and services markets. Mr. Sharp has served in senior leadership roles with five venture-backed companies – as Chief Executive Officer of CYTOO, Inc. and ArunA Biomedical, Chief Commercial Officer of BioProcessors Corporation (acquired by Seahorse Biosciences), SVP Business Development of Cellomics (acquired by Fisher International), and VP Business Development of Gentra Systems (acquired by Qiagen). Earlier career includes senior leadership roles with Life Technologies, General Manager of Terumo Medical, Vice President of Sales and Marketing at Heraeus Instruments and roles of increasing responsibility within the diagnostics business of Baxter Healthcare and a medical device subsidiary of Eli Lilly. Mr. Sharp has successfully commercialized more than 500 products and services. Earned M.S. and B.A. degrees from the Pennsylvania State University. www.linkedin.com/in/billsharp1


Co-founder, Director, Scientific Advisor

Dr. Demirci is a Professor with tenure and Co-division Chief, Canary Center for Cancer Early Detection, Department of Radiology at Stanford University. Before moving to Stanford, he was Associate Professor of Medicine and Health Sciences and Technology at the Harvard Medical School (HMS) and Massachusetts Institute of Technology (MIT). He received a bachelor’s degree (summa cum laude) from the University of Michigan, Ann Arbor; master’s degrees in Electrical Engineering in 2001 and in Management Science and Engineering in 2005, as well as a PhD in Electrical Engineering in 2005 all from Stanford University. Dr. Demirci is an academic entrepreneur with seminal contributions to the development of innovative microfluidic platform technologies in medicine for broad applications in fertility, cell sorting, and point-of-care diagnostics. He is recipient of the Academy for Radiology & Biomedical Imaging Research (ARBIR) Distinguished Investigator Award; MIT TR-35 Award; Harvard Medical School-Young Investigator Award; Stanford Basic Scientist of the Year Award; Brigham and Women’s Hospital-Bright Future Award; IEEE EMBS Early Career Award; IEEE EMBS Translational Science Award; NSF CAREER Award; Coulter Foundation Early Career Award; and Chinese International Young Scientist Award. He holds 25 issued or pending patents, provisionals, and disclosures that have been licensed to companies. He has published 146 articles, 24 book chapters/editorials, and 4 edited books, and serves as an editorial board member for various peer-reviewed journals. Dr. Demirci is also a fellow-elect of American Institute of Medical and Biological Engineering (AIMBE). www.linkedin.com/in/utkan-demirci-292a58